FDA recognizes that there are some patients with severe gastrointestinal motility disorders that are difficult to manage with available therapy for whom domperidone’s potential benefits may justify its potential risks. Patients 12 years of age and older with certain gastrointestinal (GI) conditions
Similar Posts
www.buycodeine.us – 702527 – 05/05/2025
Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the InternetTroemner Roemner Farm Issues Allergy Alert on Undeclared Milk, Wheat, and Soy in Pfeffernusse Cookies
Troemner Farm of Atlantic Mine, MI is recalling Troemner Family Farm branded 6 oz and 12 oz Pfeffernusse Cookies, because it may contain undeclared milk, wheat, and soy. People who have an allergy or severe sensitivity to milk, wheat, or soy run the risk of serious or life-threatening allergic reactOlympus Expands Voluntary Recall for ViziShot 2 FLEX (19G) EBUS -TBNA Needles
CENTER VALLEY, Pa., (January 16, 2026) — Olympus Corporation has announced the expansion of a previous global medical device removal action for ViziShot 2 FLEX (19G) EBUS -TBNA needles (“ViziShot 2 FLEX”) after receiving and investigating complaints of device components ejecting or detaching duringMaypharm – 718717 – 11/03/2025
Unapproved New Drugs/Misbranded BotoxHTO Nevada, Inc. dba Kirkman – 719074 – 01/27/2026
CGMP/Finished Pharmaceuticals/AdulteratedEmpower Clinic Services LLC dba Empower Pharmacy. Houston, TX. 483 issued 11/14/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 11/14/2025
Short Title (70 char) Empower Clinic Services LLC dba Empower Pharmacy. Houston, TX. 483 issued 11/14/2025
FEI Number 3021758709
Firm Name Empower Clinic Services LLC dba Empower Pharmacy
Record Type